Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abdullah Al-Asmi

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Seizure|October 17, 2022
Physicians' beliefs about brain surgery for drug-resistant epilepsy: A global surveyAli A Asadi-Pooya, Francesco Brigo, Eugen Trinka, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 26, 2022
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registryTim Spelman, Serkan Ozakbas, Raed Alroughani, et al.
Neurodegenerative Disease Management|June 8, 2023
A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registryTim Spelman, Serkan Ozakbas, Raed Alroughani, et al.
Epilepsy & Behavior : E&B|February 21, 2021
Complementary and alternative medicine in epilepsy: A global survey of physicians' opinionsAli A Asadi-Pooya, Francesco Brigo, Simona Lattanzi, et al.
Journal of Neurology|April 14, 2025
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort studyPakeeran Siriratnam, Saif Huda, Anneke Van der Walt, et al.
Epilepsy & Behavior : E&B|January 30, 2022
Counseling about sudden unexpected death in epilepsy (SUDEP): A global survey of neurologists' opinionsAli A Asadi-Pooya, Eugen Trinka, Francesco Brigo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 4, 2024
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre studyPakeeran Siriratnam, Paul Sanfilippo, Anneke van der Walt, et al.
Neurology|November 19, 2024
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSDPakeeran Siriratnam, Saif Huda, Anneke Van Der Walt, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 28, 2025
Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 yearsJodie I Roberts, Sifat Sharmin, Dana Horakova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2025
Managing reactivation of multiple sclerosis during treatment with natalizumabNathaniel Lizak, Sifat Sharmin, Dana Horáková, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Seizure|October 17, 2022
Physicians' beliefs about brain surgery for drug-resistant epilepsy: A global surveyAli A Asadi-Pooya, Francesco Brigo, Eugen Trinka, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 26, 2022
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registryTim Spelman, Serkan Ozakbas, Raed Alroughani, et al.
Neurodegenerative Disease Management|June 8, 2023
A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registryTim Spelman, Serkan Ozakbas, Raed Alroughani, et al.
Epilepsy & Behavior : E&B|February 21, 2021
Complementary and alternative medicine in epilepsy: A global survey of physicians' opinionsAli A Asadi-Pooya, Francesco Brigo, Simona Lattanzi, et al.
Journal of Neurology|April 14, 2025
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD: an international cohort studyPakeeran Siriratnam, Saif Huda, Anneke Van der Walt, et al.
Epilepsy & Behavior : E&B|January 30, 2022
Counseling about sudden unexpected death in epilepsy (SUDEP): A global survey of neurologists' opinionsAli A Asadi-Pooya, Eugen Trinka, Francesco Brigo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 4, 2024
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre studyPakeeran Siriratnam, Paul Sanfilippo, Anneke van der Walt, et al.
Neurology|November 19, 2024
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSDPakeeran Siriratnam, Saif Huda, Anneke Van Der Walt, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 28, 2025
Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 yearsJodie I Roberts, Sifat Sharmin, Dana Horakova, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2025
Managing reactivation of multiple sclerosis during treatment with natalizumabNathaniel Lizak, Sifat Sharmin, Dana Horáková, et al.
Pageof 11